Profectus BioSciences' Grant

Profectus BioSciences raised a round of funding on October 14, 2010. Investors include National Institutes of Health.

Profectus Biosciences is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases. The Company's name, Profectus, when translated from its Latin roots, mean…

Articles about Profectus BioSciences' Grant: